FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions | FDA FDA.govFDA approves pioneering drug for ovarian cancer surgery Purdue News ServiceOn Target Laboratories Announces FDA Approval of CYTALUX™ (pafolacianine) injection for Identification of Ovarian Cancer During Surgery PRNewswireLensGen® Receives IDE Approval from the US FDA to Begin Clinical Study of the Juvene® Presbyopia-Correcting Intraocular Lens PRNewswireFDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions PRNewswireView Full Coverage on Google News